CSC and Immunoediting

Cancer stem cells (CSCs) can evade immune surveillance, allowing them to survive and drive tumor growth. This track focuses on the concept of immunoediting, where CSCs shape the immune response to evade detection and destruction. Researchers investigate how CSCs alter immune cell functions, such as suppressing T-cell activity and promoting regulatory T-cells, to create an immune-suppressive tumor microenvironment. Understanding the interactions between CSCs and the immune system is crucial for developing immunotherapies that can overcome immune evasion. By targeting CSC-specific mechanisms of immunoediting, researchers hope to enhance the effectiveness of cancer immunotherapies and improve patient outcomes.

    Related Conference of CSC and Immunoediting

    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 26-27, 2025

    15th World Congress on Breast Cancer

    Rome, Italy
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    August 18-19, 2025

    6th Cancer Diagnostics & Treatment Conference

    Rome, Italy
    October 13-14, 2025

    8th International Conference on Anti-Cancer Drugs & Therapies

    Aix-en-Provence, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain

    CSC and Immunoediting Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in